IBM (NYSE:IBM) Receives “Neutral” Rating from JPMorgan Chase & Co.

Share on StockTwits

JPMorgan Chase & Co. reiterated their neutral rating on shares of IBM (NYSE:IBM) in a research report released on Monday morning, Borsen Zeitung reports. They currently have a $152.00 price target on the technology company’s stock.

Several other analysts have also recently issued reports on the stock. Evercore ISI began coverage on shares of IBM in a research note on Wednesday, June 5th. They set an outperform rating and a $150.00 price objective for the company. Wells Fargo & Co boosted their price objective on shares of IBM from $140.00 to $147.00 and gave the company a market perform rating in a research note on Tuesday, August 6th. Bank of America boosted their price objective on shares of IBM from $165.00 to $170.00 and gave the company a buy rating in a research note on Monday, August 5th. Nomura boosted their price objective on shares of IBM from $165.00 to $175.00 and gave the company a buy rating in a research note on Monday, August 5th. Finally, BMO Capital Markets boosted their price objective on shares of IBM from $147.00 to $155.00 and gave the company a market perform rating in a research note on Wednesday, April 17th. They noted that the move was a valuation call. One equities research analyst has rated the stock with a sell rating, twelve have issued a hold rating and eight have given a buy rating to the company’s stock. The company presently has a consensus rating of Hold and a consensus price target of $155.29.

Shares of NYSE IBM opened at $131.92 on Monday. IBM has a 52-week low of $105.94 and a 52-week high of $154.36. The firm has a fifty day moving average of $143.11 and a 200-day moving average of $138.90. The stock has a market capitalization of $116.32 billion, a PE ratio of 9.55, a P/E/G ratio of 2.01 and a beta of 1.28. The company has a quick ratio of 1.79, a current ratio of 1.83 and a debt-to-equity ratio of 3.51.

IBM (NYSE:IBM) last announced its quarterly earnings data on Wednesday, July 17th. The technology company reported $3.17 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.06 by $0.11. IBM had a net margin of 11.22% and a return on equity of 69.56%. The company had revenue of $19.20 billion during the quarter, compared to analysts’ expectations of $19.20 billion. During the same period in the previous year, the company earned $3.08 EPS. The business’s quarterly revenue was down 4.0% compared to the same quarter last year. Equities research analysts expect that IBM will post 13.34 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 10th. Investors of record on Friday, August 9th will be given a dividend of $1.62 per share. The ex-dividend date of this dividend is Thursday, August 8th. This represents a $6.48 dividend on an annualized basis and a yield of 4.91%. IBM’s dividend payout ratio (DPR) is 46.92%.

In related news, SVP Kenneth M. Keverian sold 2,227 shares of the company’s stock in a transaction on Friday, June 14th. The shares were sold at an average price of $135.15, for a total transaction of $300,979.05. Following the completion of the sale, the senior vice president now directly owns 32,878 shares of the company’s stock, valued at approximately $4,443,461.70. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, SVP Kenneth M. Keverian sold 2,690 shares of the company’s stock in a transaction on Tuesday, June 11th. The stock was sold at an average price of $135.50, for a total transaction of $364,495.00. Following the sale, the senior vice president now directly owns 34,665 shares of the company’s stock, valued at $4,697,107.50. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 7,000 shares of company stock valued at $940,430. 0.19% of the stock is owned by corporate insiders.

A number of institutional investors have recently made changes to their positions in IBM. Next Capital Management LLC boosted its position in IBM by 50.0% in the 2nd quarter. Next Capital Management LLC now owns 213 shares of the technology company’s stock valued at $29,000 after buying an additional 71 shares during the last quarter. Braun Stacey Associates Inc. raised its stake in shares of IBM by 1.2% in the 2nd quarter. Braun Stacey Associates Inc. now owns 6,450 shares of the technology company’s stock valued at $889,000 after purchasing an additional 75 shares in the last quarter. Resource Management LLC raised its stake in shares of IBM by 3.2% in the 1st quarter. Resource Management LLC now owns 3,126 shares of the technology company’s stock valued at $441,000 after purchasing an additional 96 shares in the last quarter. Mount Vernon Associates Inc. MD raised its stake in shares of IBM by 1.5% in the 1st quarter. Mount Vernon Associates Inc. MD now owns 6,705 shares of the technology company’s stock valued at $946,000 after purchasing an additional 100 shares in the last quarter. Finally, Marietta Investment Partners LLC raised its stake in shares of IBM by 1.8% in the 1st quarter. Marietta Investment Partners LLC now owns 5,686 shares of the technology company’s stock valued at $802,000 after purchasing an additional 100 shares in the last quarter. 55.38% of the stock is owned by hedge funds and other institutional investors.

IBM Company Profile

International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers a portfolio of enterprise artificial intelligence platforms, such as analytics and data management platforms, cloud data services, talent management, and industry solutions primarily under the Watson Platform, Watson Health, and Watson Internet of Things names.

Further Reading: Short Selling

Analyst Recommendations for IBM (NYSE:IBM)

Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.